Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids

Advanced prostate cancer (PCa) patients with bone metastases are treated with androgen pathway directed therapy (APDT). However, this treatment invariably fails and the cancer becomes castration resistant. To elucidate resistance mechanisms and to provide a more predictive pre-clinical research plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sanghee, Mendoza, Theresa R., Burner, Danielle N., Muldong, Michelle T., Wu, Christina C. N., Arreola-Villanueva, Catalina, Zuniga, Abril, Greenburg, Olga, Zhu, William Y., Murtadha, Jamillah, Koutouan, Evodie, Pineda, Naomi, Pham, Hao, Kang, Sung-Gu, Kim, Hyun Tae, Pineda, Gabriel, Lennon, Kathleen M., Cacalano, Nicholas A., Jamieson, Catriona H. M., Kane, Christopher J., Kulidjian, Anna A., Gaasterland, Terry, Jamieson, Christina A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952299/
https://www.ncbi.nlm.nih.gov/pubmed/35328625
http://dx.doi.org/10.3390/ijms23063203

Ejemplares similares

Ejemplares similares